Autologous therapy involves stem cells that are harvested from a patient, stored over many weeks while the patient receives therapy for blood cancers/blood diseases and is then returned to the patient; allogenic transplantation involves a healthy donor providing the stem cells to replace the immune system after high dose chemotherapy for blood cancer/diseases.
The accreditation is effective for three years beginning Dec. 21, 2017.
FACT is an internationally recognized accrediting body for hospitals and medical institutions offering therapies that use stem cells for bone marrow transplants and immunotherapy.
"This accreditation speaks to the excellence of our program at UC Health and our dedication to provide the highest quality care for cellular therapy treatment in the region,” says Stephen Medlin, DO, associate professor in the Division of Hematology Oncology, Department of Internal Medicine, at the UC College of Medicine, UC Health oncologist and director of the Hematologic Malignancies Center within the UC Cancer Institute, where the center is housed.
FACT, a nonprofit corporation co-founded in 1996 by the International Society for Cellular Therapy and the American Society of Blood and Marrow Transplantation, establishes standards for high-quality medical and laboratory practice in cellular therapies. FACT standards are evidence-based requirements set by experts vested in the improvement and progress of cellular therapy.
FACT accreditation means that programs with this distinction have met the most rigorous standards in all aspects of stem cell therapy. In addition to submitting a lengthy application for accreditation, an on-site inspection takes place where program leadership must provide evidence of the quality of the program to an inspection team; the team tours the facility and completes an extensive review of the program.
The UC Cancer Institute Hematologic Malignancies and BMT team, as an extension of the center, includes hematology oncology specialists who focus exclusively on blood cancers as well as dedicated radiation oncologists, cancer and bone marrow transplant-trained hospitalists, pathologists, oncology nurse practitioners and nurses, pharmacists, dietitians, oncology social workers, a nurse educator for patients and caregivers and a director for clinical quality management.
The team provides "one-stop” outpatient care which also comprises on-site testing, clinical visits with physicians and nurse practitioners, outpatient stem cell collection, inpatient and outpatient chemotherapy and stem cell transplantation.
"Our philosophy is based on individualized, patient-specific treatment and is driven by the patient’s holistic needs,” says Medlin.